Several studies have shown that the course of schizophrenia (including episode duration) is independent of the familial loading.11 Given this body of evidence, a differential validity of the ICD-10 and DSM-III-R and DSM-IV

definitions of schizophrenia is unlikely. In keeping with this expectation, we found in a family study12 a similar degree of familial aggregation of schizophrenia as defined by DSM-III-R and DSM-IV or ICD-10, although Inhibitors,research,lifescience,medical the prevalence rates were very different (Table I). Table I. Cumulative lifetime prevalence rates for schizophrenia: first-degree relatives of probands with schizophrenia by two diagnostic systems. Abbreviations: DSM-III-R, Diagnostic Inhibitors,research,lifescience,medical and Statistical Manual of Mental Disorders,

Revised Third Edition; ICD-10, International … The degree of familial aggregation is indicated by the odds ratios (OR) with 1.0 indicating the risk in the general population and values higher than with 1.0 indicating the degree of increased risk with respect to the general population. A similar degree of familial aggregation is apparent for DSM-III-R and ICD-10 in Table I, although a difference in criteria for minimal episode duration may result in differences in cumulative Inhibitors,research,lifescience,medical lifetime prevalence rates. In conclusion, although DSM-III-R and ICD-10 have different definitions for schizophrenia, these differences have no relevant impact on the degree of familial aggregation. Spectrum of conditions defining the familial phenotype as exemplified by schizophrenia Another strategy to explore the boundaries of a familial disorder is to delineate the range of syndromes and durations coaggregating with schizophrenia in families. Inhibitors,research,lifescience,medical This strategy is particularly informative if relatives of schizophrenics who are likely to have a genetic vulnerability to schizophrenia (so-called obligate carriers) are investigated. Obligate carriers are relatives of schizophrenics located in the pedigree between two cases with schizophrenia, eg, the mother of a schizophrenic index case is considered to be an obligate carrier if one of her siblings or one of her parents

Inhibitors,research,lifescience,medical was also suffering from schizophrenia or another psychotic disorder (independently of the phenotype of the mother of the index case). As the familial aggregation of schizophrenia is unlikely to be due to random variation (because of the low prevalence rate in the general Dacomitinib population), or nongenetic familial factors (as evidenced by twin studies), the only remaining possibility is genetic factors. Thus, differences in the prevalence of obligate carriers of disorders, syndromes, and behavioral deviations in families of schizophrenics are likely to be expressed by the genetic diathesis of schizophrenia. Table II shows the cumulative lifetime prevalences of psychiatric scientific assays Disorders (DSM-III-R) for obligate carriers done identified in our aforementioned family study.